Articles Tagged With:
-
Full November 1, 2004 Issue in PDF
-
Moving the Goalpost
High-dose atorvastatin protects patients with acute coronary syndrome from death and major cardiovascular events better than usual dose pravastatin. -
Diligent Dental Flossing May Help Prevent Stroke
These data provide further support that inflammation in general and periodontal disease more specifically are stroke risk factors. -
Pharmacology Update: Cinacalcet HCL (Sensipar) Tablets
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer. -
Full April 29, 2004, Issue in PDF
-
Ironing Out the Risk Factors for Diabetes
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women. -
Overview of Newer Antiepileptic Drugs for Neuropathic Pain and Migraine
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized. -
Clinical Briefs
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea; Association Between C-Reactive Protein and Age-Related Macular Degeneration; VZV Reactivation in Astronauts -
Full March 15, 2004, Issue in PDF
-
Pharmacology Watch: Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis
New guidelines for the treatment of bacterial rhinosinusitis were published in the January supplement of Otolaryngology-Head and Neck Surgery by the Sinus and Allergy Health Partnership.